{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:54:32Z","timestamp":1761897272418,"version":"3.40.5"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s228342","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T22:48:48Z","timestamp":1591656528000},"page":"5199-5205","source":"Crossref","is-referenced-by-count":16,"title":["<p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data<\/p>"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-6157","authenticated-orcid":true,"given":"Guillaume","family":"Beziat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-7261","authenticated-orcid":true,"given":"Lo\u00efc","family":"Ysebaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"ref1","first-page":"1261","volume":"86","author":"Mu\u00f1oz","year":"2001","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"Lucas","year":"2019","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","volume":"100","author":"Testa","year":"2002","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-2-4","volume":"2","author":"Testa","year":"2014","journal-title":"Biomark Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/cancers11091358","volume":"11","author":"Testa","year":"2019","journal-title":"Cancers"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biomedicines7010006","volume":"7","author":"Alkharabsheh","year":"2019","journal-title":"Biomedicines"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1078-0432.CCR-19-2329","volume":"26","author":"Jen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","volume":"145","author":"Garnache\u2010Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/cancers11050595","volume":"11","author":"Sapienza","year":"2019","journal-title":"Cancers"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.18632\/oncotarget.4146","volume":"6","author":"Mart\u00edn-Mart\u00edn","year":"2015","journal-title":"Oncotarget"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.247569","author":"Wang","year":"2020","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.b.21761","volume":"98","author":"Hamadeh","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bjh.14146","volume":"174","author":"Pagano","year":"2016","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2019001144","volume":"134","author":"Taylor","year":"2019","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.hoc.2020.01.009","volume":"34","author":"Kharfan-Dabaja","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.clml.2018.07.295","volume":"18","author":"Kharfan-Dabaja","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11899-017-0425-7","volume":"12","author":"Pemmaraju","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"102928","DOI":"10.1016\/j.critrevonc.2020.102928","volume":"149","author":"Zhang","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.hoc.2020.01.012","volume":"34","author":"Deconinck","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1172\/JCI128571","volume":"129","author":"Togami","year":"2019","journal-title":"J Clin Invest"},{"key":"ref24","unstructured":"ELZONRIS_US_full_prescribing_information. Available from: https:\/\/elzonris.com\/Content\/documents\/ELZONRIS_US_Full_Prescribing_Information. Accessed May 29, 2020."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3324\/haematol.2014.111740","volume":"100","author":"Angelot-Delettre","year":"2015","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood-2018-99-119302","volume":"132","author":"Patnaik","year":"2018","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2019-131217","volume":"134","author":"Pemmaraju","year":"2019","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/leu.2017.135","volume":"31","author":"Ray","year":"2017","journal-title":"Leukemia"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1182\/blood-2019-130410","volume":"134","author":"Richardson","year":"2019","journal-title":"Blood"},{"volume-title":"CD123+ Plasmacytoid Dendritic Cells from Systemic Sclerosis Patients Are Susceptible to the Cytotoxic Activity of Tagraxofusp, a CD123-Targeted Therapy.:3","year":"2019","key":"ref32"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58695","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58695","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T22:48:51Z","timestamp":1591656531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/tagraxofusp-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-n-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2147\/ott.s228342","relation":{},"ISSN":["1178-6930"],"issn-type":[{"type":"electronic","value":"1178-6930"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}